D-0096-2026 Class II Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0096-2026 was initiated by Lannett Company Inc. on Oct 10, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 46,848 90-count bottles.

Recall details

Product Type
Drugs
Report Date
Oct 29, 2025
Initiation Date
Oct 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
46,848 90-count bottles

Product description

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide in the USA

Code information

Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0096-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0096-2026. Report a data issue: hello@regdatalab.com.